Cubist Systematic Strategies, LLC Ibere Pharmaceuticals Transaction History

Cubist Systematic Strategies, LLC

$20.3 Billion
Q2 2025

Shares

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2022 Feb 14, 2023	BUY	$9.93 - $10.09 $40,484 - $41,136	4,077 Added 5.79%	74,547 $752,000
Q3 2022 Nov 14, 2022	BUY	$0.11 - $9.94 $7,751 - $700,471	70,470 New	70,470 $698,000
Q2 2022 Aug 15, 2022	SELL	$9.77 - $9.84 $203,899 - $205,360	-20,870 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$9.69 - $9.81 $100,184 - $101,425	-10,339 Reduced 33.13%	20,870 $205,000
Q4 2021 Feb 14, 2022	BUY	$9.68 - $9.77 $302,103 - $304,911	31,209 New	31,209 $303,000

Others Institutions Holding IBER

# of Institutions

1

Shares Held

0

Call Options Held

0

Put Options Held

0

Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
100.0% of portfolio

About IBERE PHARMACEUTICALS

Ticker IBER
Exchange NYSE
Sector Financial Services
Industry Shell Companies
Shares Outstandng 13,800,000
Description
Ibere Pharmaceuticals does not have significant operations. It focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses. The company was incorporated in 2020 and is based in Philadelphia, Pennsylvania.

More about IBER

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.